(Q46531274)

22 December 2017

title

Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people (English)

1 reference

22 December 2017

metabolic dysfunction–associated steatotic liver disease

1 reference

1 reference

1 reference

based on heuristic

inferred from title

author

Anthony Wing-Hung Chan

Anthony Wing-Hong Chan

5

0 references

Francis Ka-Ming Chan

Francis Ka-Leung Chan

9

0 references

Vincent Wai-Sun Wong

1

Vincent Wai-Sun Wong

1 reference

22 December 2017

Henry Lik-Yuen Chan

11

Henry Lik-Yuen Chan

1 reference

22 December 2017

Grace Lai-Hung Wong

2

Grace Lai-Hung Wong

1 reference

22 December 2017

Paul Cheung-Lung Choi

6

Paul Cheung-Lung Choi

1 reference

22 December 2017

author name string

Steven Woon-Choi Tsang

3

1 reference

22 December 2017

Alex Yui Hui

4

1 reference

22 December 2017

Wing-Yee So

7

1 reference

22 December 2017

Ada Mei-Ling Tse

8

1 reference

22 December 2017

Joseph Jao-Yiu Sung

10

1 reference

22 December 2017

publication date

1 June 2008

1 reference

22 December 2017

Journal of Gastroenterology and Hepatology

published in

1 reference

22 December 2017

volume

23

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

914-921

1 reference

22 December 2017

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Plasma adiponectin is decreased in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age <or=50 years).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Steatohepatitis induced by intragastric overfeeding in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

How should we manage patients with non-alcoholic fatty liver disease in 2007?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05344.X

10.1111/J.1440-1746.2008.05344.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

release_ewi25eq3i5hshftlrd34yoh4wa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ewi25eq3i5hshftlrd34yoh4wa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

22 December 2017